Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The University of Regina triumphs in ninth annual CFA Societies Canada Ethics Challenge
-
Aufgusshow 2025: Canada’s first national sauna performance championship comes to Whitby this June
-
Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
-
Hanmi Financial to Participate in the D.A. Davidson 27th Annual Financial Institutions Conference
-
BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives
-
DRYWORLD and G3 Management Announce Strategic Global Partnership to Drive Growth in Sports Apparel Market
-
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
-
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends
-
BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives
-
Comscore Launches Certified Deal IDs in Magnite’s SSP, Bringing Trusted Content Rankings to Programmatic Buying
-
Navitas Redefines Reliability with Industry’s First Automotive ‘AEC-Plus’ Qualified SiC MOSFETs in HV-T2Pak Top-Side Cooled Package
-
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)
-
Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain
-
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL
-
Workhorse Group Sets First Quarter 2025 Earnings Call for Thursday, May 15, 2025 at 8:00 a.m. ET
-
Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor
-
Surfshark becomes the first company to launch privacy-oriented public DNS service
-
Transactions in Connection with Share Buy-back Program
-
G7 should act as stabilizer and reformer to reshape international order, urges T7 report
-
Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
-
Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US
-
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
-
Ocean Power Technologies Awarded Contract to Provide Multiple Unmanned Surface Vehicles for International Defense Customer
-
Navigator Gas Announces Signing of $300 Million Senior Secured Term Loan and Revolving Credit Facility
-
Aspo to publish its Interim Report for January-March 2025 on May 12, 2025
-
Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
-
MARA Announces Bitcoin Production and Mining Operation Updates for April 2025
-
Early Warning News Release Regarding the Securities of Euromax Resources Ltd.
-
Kornit Digital and Gooten Expand Access to Kornit’s Global Fulfillment Network for On-Demand Production
-
4DMT to Participate in Upcoming Investor Conferences
-
Ryman Hospitality Properties, Inc. Provides Updated Investor Presentation
-
Greenridge Exploration Announces 2025 Exploration Plans for the Blackbird Project in Northern Saskatchewan
-
SHARC Energy Announces Board of Director Changes
-
Enphase Energy to Hold 2025 Annual Meeting of Stockholders on May 14, 2025
-
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
-
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
-
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
-
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
-
iBio’s First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model
-
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
-
Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
-
Aemetis to Review First Quarter 2025 Financial Results on May 8, 2025
-
Sell Fast Chicagoland: Home Cash Buyers in Chicago Celebrate 20 Years of Delivering Swift Property Solutions
-
Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
-
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
-
BigCommerce Taps Technology Industry Veteran with Strong Record of Innovation as Chief Product Officer
-
Cerence AI and Code Factory Collaborate to Bring Voice-Powered Interaction to Self-Service Kiosks
-
Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
-
Valueex (VUEE) Exchange Opens IEO Window, Leading New Opportunities in Global Blockchain Investment
-
Voreifarem Partners with SwfcNrho Exchange to Create a Global New Paradigm for Medical Data Valuation
